QT prolongation with the use of ondansetron: A neglected and overlooked adverse effect
Ondansetron, commonly prescribed under the name ‘Onset’ in Pakistan, is one of the four FDA approved 5HT3 serotonin receptor antagonists for its antiemetic properties. It is commonly used in the prevention of postoperative, chemotherapy and radiation therapy-induced nausea and vomiting. Due to it...
Saved in:
| Main Author: | Dania Hussain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2024-04-01
|
| Series: | Journal of the Pakistan Medical Association |
| Subjects: | |
| Online Access: | https://jpma.org.pk/index.php/public_html/article/view/10825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment to: The Outcomes of Delayed Revascularization in Lower Extremity Vascular Injury: A Retrospective Cohort Study
by: Erkan Boga
Published: (2025-07-01) -
Enhancing comprehensive care: The importance of collaboration among healthcare professionals in managing chronic conditions in Australia
by: Shima Tajik, et al.
Published: (2025-03-01) -
In Patients not Suitable for Generalised Anaesthesia, Surgery for Necrotising Fasciitis under Spinal Anaesthesia should be Considered
by: Finsterer J, et al.
Published: (2025-03-01) -
Importance of Appropriate and Substantial Imaging and Pathological Information for Rare Conditions
by: Ichikawa J, et al.
Published: (2025-03-01) -
Whom can I rely on? Confronting Self-Stigma in patients undergoing methadone maintenance treatment
by: Nader Aghakhani, et al.
Published: (2024-12-01)